• In a large-scale, multiyear experiment, participants who paid for a share of their health care used fewer health services than a comparison group given free care.
A fter decades of evolution and experiment, the U.S. health care system has yet to solve a fundamental challenge: delivering quality health care to all Americans at an aff ordable price. In the coming years, new solutions will be explored and older ideas revisited. One idea that has returned to prominence is cost sharing, which involves shifting a greater share of health care expense and responsibility onto consumers. Recent public discussion of cost sharing has often cited a landmark RAND study: the Health Insurance Experiment (HIE). Although it was completed over two decades ago, in 1982, the HIE remains the only long-term, experimental study of cost sharing and its eff ect on service use, quality of care, and health. Th e purpose of this research brief is to summarize the HIE's main fi ndings and clarify its relevance for today's debate. Our goal is not to conclude that cost sharing is good or bad but to illuminate its eff ects so that policymakers can use the information to make sound decisions. United States to provide a regional and urban/rural balance. Participants were randomly assigned to one of fi ve types of health insurance plans created specifi cally for the experiment. Th ere were four basic types of fee-for-service plans: One type off ered free care; the other three types involved varying levels of cost sharing-25 percent, 50 percent, or 95 percent coinsurance (the percentage of medical charges that the consumer must pay). Th e fi fth type of health insurance plan was a nonprofi t, HMO-style group cooperative. Th ose assigned to the HMO received their care free of charge. For poorer families in plans that involved cost sharing, the amount of cost sharing was income-adjusted to one of three levels: 5, 10, or 15 percent of income. Out-of-pocket spending was capped at these percentages of income or at $1,000 annually (roughly $3,000 annually if adjusted from 1977 to 2005 levels), whichever was lower. Th e 95 percent coinsurance plan in the study closely resembled the high-deductible catastrophic plans being discussed today. Families participated in the experiment for 3-5 years. Th e upper age limit for adults at the time of enrollment was 61, so that no participants would become eligible for Medicare before the experiment ended. To assess participant service use, costs, and quality of care, RAND served as the families' insurer and processed their claims. To assess participant health, RAND administered surveys at the beginning and end of the experiment and also conducted comprehensive physical exams. Sixty percent of participants were randomly chosen to receive exams at the beginning of the study, and all received physicals at the end. Th e random use of physicals at the beginning was intended to control for possible health eff ects that might be stimulated by the physical exam alone, independent of further participation in the experiment.
Effects on Use of Health Services
Th e results showed that cost sharing reduced the use of nearly all health services. Specifi cally, • Averaged across all levels of coinsurance, participants (including both adults and children) with cost sharing made one to two fewer physician visits annually and had 20 percent fewer hospitalizations than those with free care. Declines were similar for other types of services as well, including dental visits, prescriptions, and mental health treatment (see Figures 1 and 2 ). • Consumers in the HMO-style cooperative had 39 percent fewer hospital admissions than consumers with free care in the fee-for-service system, but they had similar use of outpatient services. Spending reductions under the HMO plan were comparable to the eff ects of a higher rate of coinsurance in the fee-for-service system.
• Participants in cost sharing plans spent less on health care; this savings came from using fewer services rather than fi nding lower prices. Th ose with 25 percent coinsurance spent 20 percent less than participants with free care, and those with 95 percent coinsurance spent about 30 percent less (see Figure 3 ). • Reduced use of services resulted primarily from participants deciding not to initiate care. Once patients entered the health care system, cost sharing only modestly aff ected the intensity or cost of an episode of care.
Effects on Appropriateness of Care and on Quality of Care
Th e analysis also examined the appropriateness of the services reduced by cost sharing and the technical quality of care cost-sharing. Second, the overall level of quality for process measures was surprisingly low for all participants: criteria for quality were met only 62 percent of the time. Th ese results were discouraging at the time. What is more, recent RAND work found that health care quality may not have improved signifi cantly in the interim. Results of a 2003 nationwide study showed that quality criteria were met only 55 percent of the time. 1 Th us, despite tremendous technical progress that raises the potential value of care received, quality of care as a proportion of the best possible care has not improved in the past 20 years.
Effects on Health
In general, the reduction in services induced by cost sharing had no adverse eff ect on participants' health. However, there were exceptions. Th e poorest and sickest 6 percent of the sample at the start of the experiment had better outcomes under the free plan for 4 of the 30 conditions measured. Specifi cally, • Free care improved the control of hypertension. Th e poorest patients in the free care group who entered the experiment with hypertension saw greater reductions in blood pressure than did their counterparts with cost sharing. Th e projected eff ect was about a 10 percent reduction in mortality for those with hypertension. • Free care marginally improved vision for the poorest patients. • Free care also increased the likelihood among the poorest patients of receiving needed dental care. • Serious symptoms 2 were less prevalent for poorer people on the free plan. • Cost sharing also had some benefi cial eff ects. Participants in cost sharing plans worried less about their health and had fewer restricted-activity days (including time spent in seeking medical care).
Likewise, patient satisfaction, another outcome of interest, was generally high and did not vary at diff erent levels of cost sharing among the fee-for-service plans. While health outcomes at the HMO were no diff erent than outcomes for those with free care, patient satisfaction was lower among participants initially assigned to the HMO. Th ese partici-received by participants. Did cost sharing deter participants from seeking appropriate care to a greater or lesser extent than it deterred ineff ective care? To answer this question, analysts grouped specifi c conditions into seven categories according to the degree to which outpatient care and therapies were known to be eff ective in treating each condition. Th e categories ranged from conditions for which care is highly eff ective to conditions for which care is rarely eff ective.
Th e analysis found that cost sharing reduced the use of eff ective and less-eff ective care across the board (see the table). For hospitalizations and prescription drug use, cost sharing likewise reduced more-eff ective and less-eff ective care in roughly equal amounts for all participants. Th e proportion of inappropriate hospitalizations was the same (23 percent) for cost-sharing and free-plan participants, as was the inappropriate use of antibiotics.
In addition to measuring the appropriateness of care sought by patients, the experiment measured the quality of care delivered. Analysts constructed process measures of the quality of ambulatory and dental care received by HIE participants. Th e process measures dealt with the appropriate use of visits and diagnostic tests by providers and the appropriate use of therapeutic interventions after participants sought care.
Two striking fi ndings emerged: First, cost sharing did not signifi cantly aff ect the quality of care received by participants. Clinically meaningful diff erences between the free plan and cost sharing plans appeared only for the process criteria dealing with the need for an offi ce visit: 59 percent for free-plan participants versus 52 percent for those under 
Figure 3 Participants with Cost Sharing Spent Less on Health Care Services
pants were less satisfi ed with care overall than either those who had previously chosen to be in the HMO or those who remained in the fee-for-service system. Finally, the experiment examined whether shouldering more of their own health care costs leads people to take better care of themselves. It did not. Risky behaviors were not aff ected-rates of smoking and obesity, for instance, did not change.
Implications for Today's Health Care Reform Discussion
Today's health care environment diff ers in fundamental ways from the one in which the HIE took place. Th e science of medicine has changed across all dimensions. Managed care has become more prominent, as has prescription drug use. Doctors emphasize preventive care to a greater extent and know more about providing it. Given these and many other systemic changes, it is impossible to know whether a similar experiment undertaken today would produce similar results.
It is possible to take two contrasting perspectives on the HIE's relevance to today's health care debate. On the one hand, the study raises the possibility that cost sharing can be adapted to help achieve fundamental goals: containing costs and reducing waste without damaging health or quality of care. Would pairing some form of cost sharing and managed care allow us to exploit cost sharing's benefi ts (reduced costs and unnecessary care, small overall health eff ects) while avoiding its negatives (reduction in needed care, some health eff ects for poorer and sicker patients)? Th e study suggested that cost sharing should be minimal or nonexistent for the poor, especially those with chronic disease.
On the other hand, the HIE showed that cost sharing can be a blunt tool. It reduced both needed and unneeded health services. Indeed, subsequent RAND work on appropriateness of care found that economic incentives by themselves do not improve appropriateness of care or lead to clinically sensible reductions in service use. 3 In addition, cost sharing may not address the principal causes of cost growth. Cost sharing cuts expenditures by reducing visits but has little eff ect on the cost of treatment once care is sought. If, as is widely believed, cost increases are driven by treatment expense and new technologies, cost sharing can contribute to reducing costs at each point in time but may have little eff ect on the overall rate of cost growth.
Testing the eff ects of cost sharing in today's environment and determining its usefulness as a tool for health system reform would require another large-scale demonstration. To our knowledge, no such demonstration has been conducted since the HIE. However, important nonexperimental work has been done in the interim using the HIE's fi ndings on the eff ect of cost sharing in more targeted insurance plans. A recent series of RAND studies showed that cutting prescription co-payments for patients who needed cholesterollowering drugs the most could improve their health and save more than $1 billion annually in medical costs by increasing adherence and reducing the chance of hospitalization. 4 Cost Sharing Reduced the Use of Medical Services at all Levels of Effectiveness this instance, reduced cost sharing led to greater savings and improved health. As health reform reenters the national policy dialogue, RAND Health is once again providing a framework and objective analysis to inform the evaluation of options. Th e Comprehensive Assessment of Reform Eff orts (COMPARE) initiative is developing a multidimensional framework within which a variety of proposed solutions to the problems in the U.S. health care system can be evaluated. RAND Health will use a variety of analytic tools including microsimulation to explore the expected performance of the health care system over the next two decades in the absence of signifi cant policy change (i.e., establish a base case). Proposals for change will be evaluated in comparison to the base case. Th is work continues the role that RAND Health began with the HIE by providing the facts and analysis necessary for informing health policy.
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